Diabetes In Control Ulrik M. Mogensen, MD, of the department of cardiology at University Hospital Rigshospitalet in Denmark, and colleagues evaluated patients receiving sulfonylurea with insulin and 16,910 patients receiving metformin with insulin to determine the ...
Medscape Whether or not you're a proponent of the Affordable Care Act, better known as Obamacare, people with diabetes can find a lot to like about it. The first to benefit from the new legislation were young adults, who can now stay on a parent's insurance ...
Medscape This was not the case with the group who received aggressive sulfonylurea treatment. At the end of the primary study, clinicians or investigators were allowed to re-treat their patients in any way they chose, without any defined protocol. No legacy ...
AJMC.com Managed Markets Network One trial evaluated patients on metformin at baseline with add-on canagliflozin 100 mg, canagliflozin 300 mg, or sitagliptin 100 mg; the other trial evaluated patients on metformin and a sulfonylurea at baseline with add-on canagliflozin 300 mg or ... and more »
Monthly Prescribing Reference No increased risk of cancer of all sites was seen in patients taking other first diabetes medication ( sulfonylurea , insulin, or other medication but metformin) compared to patients taking metformin as first diabetes medication. While this study ...
Diabetes In Control They followed current standard of care guidelines in initiation of metformin first, followed by the addition of a sulfonylurea , then addition of a DPP-4 inhibitor, a thiazolidinedione or non-insulin injectable, followed by initiating basal insulin and ...
The Pharmaceutical Journal Joanna is a freelance medical writer with a BSc (Hons) in Medical Science & Pharmacology and 15 years' experience working in the field of medical communications. Journalistic work includes clinical research summaries, interviews, feature articles and ...
Genetic Engineering & Biotechnology News Cibus, a San Diego-based agbio firm with a proprietary gene-editing platform, had its sulfonylurea herbicide tolerant canola approved first in the U.S. and more recently in Canada, making it the only example of a company founded on genomic editing to ...
AJMC.com Managed Markets Network Study Design: Patients with T2DM who were treated with saxagliptin (N = 13,929), sulfonylurea (N = 117,756), or sitagliptin (N = 36,813) in 2010 or later were identified in a database of commercially insured beneficiaries. Patients were required to ...
